ISSN: 2639-2038
Authors: Santibañez PC*
In the current pharmacoepidemiological context, the objective of this study arises, to evaluate the influence of the effects caused by the pandemic on the consumption of anxiolytic, relaxant and sleep- inducing drugs in this population during the years 2019, 2020 and 2021, in the context of world evidence that refers to a negative psychosocial impact on people's mental health. During the 20th century there were significant changes in the demographic profiles and mortality in all regions of the world, although with different magnitudes, as is the case with the user population of the commune of Lanco, which is mostly adult and, in large number, belonging to native peoples. This study is observational, descriptive cross-sectional. Consumption data was collected from the hospital electronic record of all outpatients, who had consumption of any of the six drugs previously characterized as anxiolytics, relaxants and hypnotics and that are available in the pharmacological arsenal of this establishment. The results of all the drugs studied coincide with a profile of a patient mainly older than 55 years, female, of urban residence. Another relevant aspect is the increase in the consumption of these medications in the years studied, having as reference year the pre-pandemic consumption (2019). We can conclude that the use of benzodiapzepines must adhere to the ministerial regulations still in force. Do not prescribe hypnotic drugs for more than 6 months and include a comprehensive evaluation of the patient before prescription. Finally, it would be possible to know the influence of the development of the pandemic in Chile and the consumption of this group of drugs, carrying out, in another study, other statistical tests that manage to demonstrate or rule out such relationships, for now this is a first approach to this hypothesis investigative.
Keywords: Mental Health; Population; Consumption; Cyclobenzaprine
